Category: Prescription Drugs
Most Popular Types: Gilenya, MS Phase 3 Fingolimod TRANSFORMS, MS Phase 3 Study Fingolimod FREEDOMS II (Show all)
See also: FTY720 (Fingolimod) Clinical Trial
Sort by: Helpfulness | Most Recent
26 patient evaluations for Fingolimod taken for the purpose of 'MS (Multiple Sclerosis)'
| Date | Dosage | Perceived effectiveness | Side Effects | Adherence | Burden |
|---|---|---|---|---|---|
| Jun 18, 2013 | 0.5 mg Daily | ||||
| Oct 20, 2010 | 0.5 mg Daily |
| Date | Dosage | Perceived effectiveness | Side Effects | Adherence | Burden |
|---|---|---|---|---|---|
| Jun 18, 2013 | 0.5 mg Daily |
| Date | Dosage | Perceived effectiveness | Side Effects | Adherence | Burden |
|---|---|---|---|---|---|
| Jun 18, 2013 | 0.5 mg Daily | ||||
| Oct 14, 2010 | 0.5 mg Daily |
| Date | Dosage | Perceived effectiveness | Side Effects | Adherence | Burden |
|---|---|---|---|---|---|
| Mar 04, 2013 | 0.5 cap(s) Daily |
| Date | Dosage | Perceived effectiveness | Side Effects | Adherence | Burden |
|---|---|---|---|---|---|
| Aug 14, 2012 | 500 intl units Daily |
| Date | Dosage | Perceived effectiveness | Side Effects | Adherence | Burden |
|---|---|---|---|---|---|
| Jul 15, 2012 | 0.5 mg Daily |
| Date | Dosage | Perceived effectiveness | Side Effects | Adherence | Burden |
|---|---|---|---|---|---|
| Jul 10, 2012 | 0.5 mg Daily |
| Date | Dosage | Perceived effectiveness | Side Effects | Adherence | Burden |
|---|---|---|---|---|---|
| Jul 09, 2012 | 0.5 mg Daily |
| Date | Dosage | Perceived effectiveness | Side Effects | Adherence | Burden |
|---|---|---|---|---|---|
| Jun 15, 2012 | 20 mg Daily |
| Date | Dosage | MS (Multiple Sclerosis) Perceived effectiveness | to slow down progression Perceived effectiveness | Side Effects | Adherence | Burden |
|---|---|---|---|---|---|---|
| May 24, 2012 | ||||||
| May 11, 2012 | 0.5 mg Daily |